About GC Biopharma
GC Biopharma is a company founded in 1967. It operates as a B2B. GC Biopharma operates in a competitive market with competitors including Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
- SectorsHealthcare
- Website gcbiopharma.com
Competitors of GC Biopharma
GC Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neovacs.com | 1993 | Paris, France | $17.91M | – | Vaccine manufacturing services are provided by Neovacs CDMO. | |
| intravacc.nl | 2012 | Bilthoven, Netherlands | – | – | Vaccine development services for bacterial and viral vaccines are provided. | |
| finabio.net | 2006 | Rockville, United States | $3M | – | Biotechnology company specializing in bioconjugation services mainly for vaccine development | |
| yapanbio.com | 2019 | Hyderabad, India | $13.4M | 69 | Contract manufacturing of bio-therapeutics and vaccines is provided. | |
| veraxa.com | 2017 | Heidelberg, Germany | $3.41M | – | Antibody therapeutics for cancer treatment are developed via microfluidic screening. | |
| primrosebio.com | 2023 | San Diego, United States | $15M | – | New molecules are discovered, developed, and manufactured in biotechnology. | |
| westvacpharma.com | 2021 | Lanzhou, China | – | – | COVID-19 vaccines are manufactured via CDMO services by WestVac Biopharma. | |
| vaxform.com | 2010 | Lehigh, United States | – | – | Vaccine formulation development and consulting services are offered. |
Detailed competitors of GC Biopharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GC Biopharma
Websites that share an audience with GC Biopharma (gcbiopharma.com).
Websites whose visitors overlap most with GC Biopharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gccompany.co.kr | 86% | 69.4K | #426,882 | View details | |
| greencrosswb.com | 29% | 14.4K | – | View details |
Latest news on Gc Biopharma
Complete news archive for GC Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to GC Biopharma
10 companies that operate in the same segment as GC Biopharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GC Biopharma
GC Biopharma was founded in 1967.
GC Biopharma, established in 1967, excels in providing healthcare solutions, biopharmaceuticals, producing manufactured goods, and vaccine production. Functions as a CDMO focused on manufacturing vaccines. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.